Medical Science Liaison Management: Performance Measurement, Budget and Challenges/Lessons Learned

STUDY OVERVIEW

The role of Medical Science Liaisons (MSL) has continued to steadily grow within the healthcare industry. Consequently, Medical Affairs leaders must now, more than ever, re-assess their MSL management practices to be successful in this competitive environment. The study captures critical insights regarding MSL team performance measurement, budget allocations and challenges/lessons learned.

This research presents 2014 data versus data from 2011, and examines the growing roles and responsibilities of Medical Science Liaisons within leading healthcare organizations. Medical Affairs leaders can use this study as a benchmark for future strategic and resource planning and best-practice implementation for the medical science liaison function.

KEY TOPICS

• Value Associated with MSL and Measuring Effectiveness
• Budget Allocated to MSL
• Challenges & Lessons Learned

• Professional background of benchmark class participants
• Role within Medical Affairs of benchmark class participants
• Number of approved products
• Value associated with MSL responsibilities
• Other valued MSL responsibility & activity areas
• Effectiveness of quantitative metrics
• Effectiveness of qualitative metrics
• Optimal re-allocation of time spent on MSL activities
• Activities where MSLs should spend time
• Annual budget for MSL function in ($M)
• Breakup of MSL budget
• Funding source for MSLs
• Factors affecting annual MSL budget
• Top MSL deployment challenges
• Top challenges for MSLs
• Top lessons learned
• Important lessons to strengthen relationships and market position

Industries Profiled:
Pharmaceutical; Biotech; Manufacturing; Medical Device; Consumer Products; Diagnostic; Chemical; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbvie; AstraZeneca Pharmaceuticals; Biogen; BARD; Baxter International; Bayer Healthcare; Covidien; Genentech; Gilead Sciences; Kadmon Pharmaceuticals; Medtronic; Sanofi; Shire; ViiV Healthcare; Jazz Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.